Prima BioMed and Neopharm Group Execute Final Agreement for CVac License

[at noodls] – 21 February 2014 Prima BioMed und die Neopharm Group schließen finale Vereinbarung über CVac-Lizenz ENGLISH Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (Prima, the Company) is pleased … more

View todays social media effects on PBMD

View the latest stocks trending across Twitter. Click to view dashboard

See who Prima is hiring next, click here to view